Extremely potent monoclonal antibodies neutralize Omicron and other SARS-CoV-2 variants

Zhaochun Chen, Peng Zhang, Yumiko Matsuoka, Yaroslav Tsybovsky, Kamille West, Celia Santos, Lisa F. Boyd, Hanh Nguyen, Anna Pomerenke, Tyler Stephens, Adam S. Olia, Valeria De Giorgi, Michael R. Holbrook, Robin Gross, Elena Postnikova, Nicole L. Garza, Reed F. Johnson, David H. Margulies, Peter D. Kwong, Harvey J. Alter, Ursula J. Buchholz, Paolo Lusso, Patrizia Farci
doi: https://doi.org/10.1101/2022.01.12.22269023

Article Information

doi 
https://doi.org/10.1101/2022.01.12.22269023
History 
  • January 13, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.

Author Information

  1. Zhaochun Chen1,#,
  2. Peng Zhang2,
  3. Yumiko Matsuoka3,*,
  4. Yaroslav Tsybovsky4,*,
  5. Kamille West5,
  6. Celia Santos3,
  7. Lisa F. Boyd6,
  8. Hanh Nguyen1,
  9. Anna Pomerenke1,
  10. Tyler Stephens4,
  11. Adam S. Olia7,
  12. Valeria De Giorgi5,
  13. Michael R. Holbrook8,
  14. Robin Gross8,
  15. Elena Postnikova8,
  16. Nicole L. Garza9,
  17. Reed F. Johnson9,
  18. David H. Margulies6,
  19. Peter D. Kwong7,
  20. Harvey J. Alter5,
  21. Ursula J. Buchholz3,
  22. Paolo Lusso2 and
  23. Patrizia Farci1,#
  1. 1Hepatic Pathogenesis Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
  2. 2Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
  3. 3RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
  4. 4Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA
  5. 5Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA
  6. 6Molecular Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
  7. 7Vaccine Research Center, National Institute of Allergy and Infectious Diseases National Institutes of Health, Bethesda, Maryland, USA
  8. 8National Institute of Allergy and Infectious Diseases (NIAID) Integrated Research Facility, National Institutes of Health, Frederick, Maryland, USA
  9. 9SARS-CoV-2 Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
  1. ↵#Correspondence: zchen{at}niaid.nih.gov; pfarci{at}niaid.nih.gov
Back to top
Posted January 13, 2022.
Download PDF
Data/Code
Email
Extremely potent monoclonal antibodies neutralize Omicron and other SARS-CoV-2 variants
Zhaochun Chen, Peng Zhang, Yumiko Matsuoka, Yaroslav Tsybovsky, Kamille West, Celia Santos, Lisa F. Boyd, Hanh Nguyen, Anna Pomerenke, Tyler Stephens, Adam S. Olia, Valeria De Giorgi, Michael R. Holbrook, Robin Gross, Elena Postnikova, Nicole L. Garza, Reed F. Johnson, David H. Margulies, Peter D. Kwong, Harvey J. Alter, Ursula J. Buchholz, Paolo Lusso, Patrizia Farci
medRxiv 2022.01.12.22269023; doi: https://doi.org/10.1101/2022.01.12.22269023
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area